nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—ABCB1—peripheral nervous system neoplasm	0.208	1	CbGaD
Zidovudine—ABCC5—Cisplatin—peripheral nervous system neoplasm	0.0753	0.144	CbGbCtD
Zidovudine—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0516	0.0989	CbGbCtD
Zidovudine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0491	0.0941	CbGbCtD
Zidovudine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0489	0.0937	CbGbCtD
Zidovudine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0339	0.0649	CbGbCtD
Zidovudine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0264	0.0505	CbGbCtD
Zidovudine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0242	0.0464	CbGbCtD
Zidovudine—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0209	0.04	CbGbCtD
Zidovudine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0195	0.0373	CbGbCtD
Zidovudine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0191	0.0366	CbGbCtD
Zidovudine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0176	0.0338	CbGbCtD
Zidovudine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0176	0.0338	CbGbCtD
Zidovudine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0169	0.0324	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.013	0.025	CbGbCtD
Zidovudine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0122	0.0234	CbGbCtD
Zidovudine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0106	0.0202	CbGbCtD
Zidovudine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0102	0.0195	CbGbCtD
Zidovudine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00981	0.0188	CbGbCtD
Zidovudine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00752	0.0144	CbGbCtD
Zidovudine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00723	0.0139	CbGbCtD
Zidovudine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00701	0.0134	CbGbCtD
Zidovudine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00689	0.0132	CbGbCtD
Zidovudine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0047	0.00901	CbGbCtD
Zidovudine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00451	0.00864	CbGbCtD
Zidovudine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00413	0.00792	CbGbCtD
Zidovudine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00282	0.0054	CbGbCtD
Zidovudine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	9.78e-05	0.000455	CcSEcCtD
Zidovudine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	9.78e-05	0.000455	CcSEcCtD
Zidovudine—Nausea—Topotecan—peripheral nervous system neoplasm	9.77e-05	0.000454	CcSEcCtD
Zidovudine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	9.74e-05	0.000453	CcSEcCtD
Zidovudine—Confusional state—Etoposide—peripheral nervous system neoplasm	9.73e-05	0.000453	CcSEcCtD
Zidovudine—Nausea—Isotretinoin—peripheral nervous system neoplasm	9.69e-05	0.000451	CcSEcCtD
Zidovudine—Nausea—Tretinoin—peripheral nervous system neoplasm	9.69e-05	0.000451	CcSEcCtD
Zidovudine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	9.65e-05	0.000449	CcSEcCtD
Zidovudine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.000449	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	9.6e-05	0.000447	CcSEcCtD
Zidovudine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	9.57e-05	0.000445	CcSEcCtD
Zidovudine—Nausea—Melphalan—peripheral nervous system neoplasm	9.57e-05	0.000445	CcSEcCtD
Zidovudine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000443	CcSEcCtD
Zidovudine—Influenza—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000443	CcSEcCtD
Zidovudine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.46e-05	0.00044	CcSEcCtD
Zidovudine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	9.45e-05	0.00044	CcSEcCtD
Zidovudine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	9.42e-05	0.000438	CcSEcCtD
Zidovudine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.42e-05	0.000438	CcSEcCtD
Zidovudine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	9.39e-05	0.000437	CcSEcCtD
Zidovudine—Skin disorder—Etoposide—peripheral nervous system neoplasm	9.38e-05	0.000436	CcSEcCtD
Zidovudine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	9.33e-05	0.000434	CcSEcCtD
Zidovudine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	9.33e-05	0.000434	CcSEcCtD
Zidovudine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.000428	CcSEcCtD
Zidovudine—Anorexia—Etoposide—peripheral nervous system neoplasm	9.2e-05	0.000428	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000427	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000427	CcSEcCtD
Zidovudine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	9.16e-05	0.000426	CcSEcCtD
Zidovudine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	9.13e-05	0.000424	CcSEcCtD
Zidovudine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000424	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	9.1e-05	0.000423	CcSEcCtD
Zidovudine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.00042	CcSEcCtD
Zidovudine—Pain—Cisplatin—peripheral nervous system neoplasm	9.01e-05	0.000419	CcSEcCtD
Zidovudine—Dysuria—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000414	CcSEcCtD
Zidovudine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000414	CcSEcCtD
Zidovudine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.87e-05	0.000413	CcSEcCtD
Zidovudine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000409	CcSEcCtD
Zidovudine—Influenza—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000409	CcSEcCtD
Zidovudine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000409	CcSEcCtD
Zidovudine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.75e-05	0.000407	CcSEcCtD
Zidovudine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.68e-05	0.000404	CcSEcCtD
Zidovudine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.67e-05	0.000403	CcSEcCtD
Zidovudine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	8.63e-05	0.000401	CcSEcCtD
Zidovudine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.0004	CcSEcCtD
Zidovudine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.61e-05	0.0004	CcSEcCtD
Zidovudine—Somnolence—Etoposide—peripheral nervous system neoplasm	8.58e-05	0.000399	CcSEcCtD
Zidovudine—Asthenia—Vincristine—peripheral nervous system neoplasm	8.55e-05	0.000398	CcSEcCtD
Zidovudine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.48e-05	0.000394	CcSEcCtD
Zidovudine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.46e-05	0.000394	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000391	CcSEcCtD
Zidovudine—Rash—Dactinomycin—peripheral nervous system neoplasm	8.41e-05	0.000391	CcSEcCtD
Zidovudine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.39e-05	0.00039	CcSEcCtD
Zidovudine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000389	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.33e-05	0.000388	CcSEcCtD
Zidovudine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.33e-05	0.000387	CcSEcCtD
Zidovudine—Fatigue—Etoposide—peripheral nervous system neoplasm	8.32e-05	0.000387	CcSEcCtD
Zidovudine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000387	CcSEcCtD
Zidovudine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000385	CcSEcCtD
Zidovudine—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000385	CcSEcCtD
Zidovudine—Pain—Etoposide—peripheral nervous system neoplasm	8.25e-05	0.000384	CcSEcCtD
Zidovudine—Constipation—Etoposide—peripheral nervous system neoplasm	8.25e-05	0.000384	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000383	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000383	CcSEcCtD
Zidovudine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.18e-05	0.00038	CcSEcCtD
Zidovudine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.15e-05	0.000379	CcSEcCtD
Zidovudine—Sweating—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000378	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000378	CcSEcCtD
Zidovudine—Haematuria—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000376	CcSEcCtD
Zidovudine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.02e-05	0.000373	CcSEcCtD
Zidovudine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000372	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.00037	CcSEcCtD
Zidovudine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.00037	CcSEcCtD
Zidovudine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.95e-05	0.00037	CcSEcCtD
Zidovudine—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.92e-05	0.000368	CcSEcCtD
Zidovudine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.92e-05	0.000368	CcSEcCtD
Zidovudine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.89e-05	0.000367	CcSEcCtD
Zidovudine—Dizziness—Vincristine—peripheral nervous system neoplasm	7.88e-05	0.000367	CcSEcCtD
Zidovudine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.86e-05	0.000366	CcSEcCtD
Zidovudine—Rash—Alitretinoin—peripheral nervous system neoplasm	7.8e-05	0.000363	CcSEcCtD
Zidovudine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.79e-05	0.000362	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000362	CcSEcCtD
Zidovudine—Headache—Alitretinoin—peripheral nervous system neoplasm	7.75e-05	0.00036	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000358	CcSEcCtD
Zidovudine—TERT—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	7.68e-05	0.00139	CbGpPWpGaD
Zidovudine—Urticaria—Etoposide—peripheral nervous system neoplasm	7.67e-05	0.000357	CcSEcCtD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.66e-05	0.00138	CbGpPWpGaD
Zidovudine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000356	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000356	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000355	CcSEcCtD
Zidovudine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.63e-05	0.000355	CcSEcCtD
Zidovudine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.63e-05	0.000355	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000354	CcSEcCtD
Zidovudine—Vomiting—Vincristine—peripheral nervous system neoplasm	7.58e-05	0.000352	CcSEcCtD
Zidovudine—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.56e-05	0.000352	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000352	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.00035	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.00035	CcSEcCtD
Zidovudine—Rash—Vincristine—peripheral nervous system neoplasm	7.51e-05	0.000349	CcSEcCtD
Zidovudine—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.51e-05	0.000349	CcSEcCtD
Zidovudine—TERT—TCF dependent signaling in response to WNT—AKT1—peripheral nervous system neoplasm	7.51e-05	0.00135	CbGpPWpGaD
Zidovudine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	7.48e-05	0.000348	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000348	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000347	CcSEcCtD
Zidovudine—Headache—Vincristine—peripheral nervous system neoplasm	7.47e-05	0.000347	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	7.42e-05	0.000345	CcSEcCtD
Zidovudine—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	7.42e-05	0.00134	CbGpPWpGaD
Zidovudine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000344	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000343	CcSEcCtD
Zidovudine—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.35e-05	0.000342	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000341	CcSEcCtD
Zidovudine—TERT—RNF mutants show enhanced WNT signaling and proliferation—AKT1—peripheral nervous system neoplasm	7.27e-05	0.00131	CbGpPWpGaD
Zidovudine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.21e-05	0.000335	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000335	CcSEcCtD
Zidovudine—Nausea—Vincristine—peripheral nervous system neoplasm	7.08e-05	0.000329	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000329	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000329	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000328	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000325	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.000324	CcSEcCtD
Zidovudine—Asthenia—Etoposide—peripheral nervous system neoplasm	6.93e-05	0.000322	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000322	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000321	CcSEcCtD
Zidovudine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000319	CcSEcCtD
Zidovudine—Chills—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000318	CcSEcCtD
Zidovudine—Pruritus—Etoposide—peripheral nervous system neoplasm	6.83e-05	0.000318	CcSEcCtD
Zidovudine—TERT—Signaling by WNT in cancer—AKT1—peripheral nervous system neoplasm	6.75e-05	0.00122	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.71e-05	0.00121	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.7e-05	0.00121	CbGpPWpGaD
Zidovudine—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.7e-05	0.000312	CcSEcCtD
Zidovudine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.00031	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.00031	CcSEcCtD
Zidovudine—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.65e-05	0.0012	CbGpPWpGaD
Zidovudine—Rash—Cisplatin—peripheral nervous system neoplasm	6.64e-05	0.000309	CcSEcCtD
Zidovudine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.64e-05	0.000309	CcSEcCtD
Zidovudine—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.63e-05	0.0012	CbGpPWpGaD
Zidovudine—Erythema—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000308	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000308	CcSEcCtD
Zidovudine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.6e-05	0.000307	CcSEcCtD
Zidovudine—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	6.59e-05	0.00119	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.57e-05	0.00119	CbGpPWpGaD
Zidovudine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000304	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000304	CcSEcCtD
Zidovudine—Tension—Epirubicin—peripheral nervous system neoplasm	6.51e-05	0.000303	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000302	CcSEcCtD
Zidovudine—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.45e-05	0.00116	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GNS—peripheral nervous system neoplasm	6.44e-05	0.00116	CbGpPWpGaD
Zidovudine—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.0003	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.43e-05	0.00116	CbGpPWpGaD
Zidovudine—Back pain—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000298	CcSEcCtD
Zidovudine—Dizziness—Etoposide—peripheral nervous system neoplasm	6.38e-05	0.000297	CcSEcCtD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.38e-05	0.00115	CbGpPWpGaD
Zidovudine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000296	CcSEcCtD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.37e-05	0.00115	CbGpPWpGaD
Zidovudine—TK1—Metabolism—GNAS—peripheral nervous system neoplasm	6.36e-05	0.00115	CbGpPWpGaD
Zidovudine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000295	CcSEcCtD
Zidovudine—Chills—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000294	CcSEcCtD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.31e-05	0.00114	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.27e-05	0.00113	CbGpPWpGaD
Zidovudine—Nausea—Cisplatin—peripheral nervous system neoplasm	6.26e-05	0.000291	CcSEcCtD
Zidovudine—TK1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.24e-05	0.00113	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—NME1—peripheral nervous system neoplasm	6.17e-05	0.00111	CbGpPWpGaD
Zidovudine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000287	CcSEcCtD
Zidovudine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000286	CcSEcCtD
Zidovudine—Vomiting—Etoposide—peripheral nervous system neoplasm	6.14e-05	0.000285	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000285	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000285	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000285	CcSEcCtD
Zidovudine—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.09e-05	0.0011	CbGpPWpGaD
Zidovudine—Rash—Etoposide—peripheral nervous system neoplasm	6.09e-05	0.000283	CcSEcCtD
Zidovudine—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.08e-05	0.000283	CcSEcCtD
Zidovudine—Headache—Etoposide—peripheral nervous system neoplasm	6.05e-05	0.000281	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000281	CcSEcCtD
Zidovudine—Tension—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.00028	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000279	CcSEcCtD
Zidovudine—Malaise—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000278	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000277	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000277	CcSEcCtD
Zidovudine—Syncope—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000277	CcSEcCtD
Zidovudine—ABCC5—Metabolism—COX2—peripheral nervous system neoplasm	5.94e-05	0.00107	CbGpPWpGaD
Zidovudine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000276	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000276	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000274	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000271	CcSEcCtD
Zidovudine—Cough—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000269	CcSEcCtD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.78e-05	0.00104	CbGpPWpGaD
Zidovudine—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000267	CcSEcCtD
Zidovudine—Nausea—Etoposide—peripheral nervous system neoplasm	5.73e-05	0.000267	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000265	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000264	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000263	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000263	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000263	CcSEcCtD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.63e-05	0.00102	CbGpPWpGaD
Zidovudine—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000262	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.61e-05	0.000261	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000259	CcSEcCtD
Zidovudine—TERT—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	5.56e-05	0.001	CbGpPWpGaD
Zidovudine—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000257	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000256	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000256	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.5e-05	0.000992	CbGpPWpGaD
Zidovudine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000255	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000254	CcSEcCtD
Zidovudine—Oedema—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000252	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000252	CcSEcCtD
Zidovudine—ABCC5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.4e-05	0.000975	CbGpPWpGaD
Zidovudine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.000251	CcSEcCtD
Zidovudine—ABCC5—Disease—PPP3R1—peripheral nervous system neoplasm	5.38e-05	0.000971	CbGpPWpGaD
Zidovudine—Cough—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000249	CcSEcCtD
Zidovudine—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	5.34e-05	0.000963	CbGpPWpGaD
Zidovudine—Shock—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000248	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000247	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.31e-05	0.000247	CcSEcCtD
Zidovudine—ABCC5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.3e-05	0.000957	CbGpPWpGaD
Zidovudine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000246	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.000244	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.24e-05	0.000945	CbGpPWpGaD
Zidovudine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000243	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000243	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000243	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000243	CcSEcCtD
Zidovudine—TERT—Cell Cycle—MYC—peripheral nervous system neoplasm	5.21e-05	0.00094	CbGpPWpGaD
Zidovudine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000242	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.19e-05	0.000241	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.00024	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.00024	CcSEcCtD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.13e-05	0.000927	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.12e-05	0.000924	CbGpPWpGaD
Zidovudine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000235	CcSEcCtD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.03e-05	0.000907	CbGpPWpGaD
Zidovudine—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000233	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000233	CcSEcCtD
Zidovudine—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	4.95e-05	0.000893	CbGpPWpGaD
Zidovudine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000229	CcSEcCtD
Zidovudine—Shock—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000229	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000228	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000228	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000228	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000226	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000226	CcSEcCtD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.85e-05	0.000876	CbGpPWpGaD
Zidovudine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000225	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000224	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000224	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.81e-05	0.000867	CbGpPWpGaD
Zidovudine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000222	CcSEcCtD
Zidovudine—TERT—Disease—PTPN11—peripheral nervous system neoplasm	4.77e-05	0.000861	CbGpPWpGaD
Zidovudine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000222	CcSEcCtD
Zidovudine—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	4.76e-05	0.000859	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	4.75e-05	0.000857	CbGpPWpGaD
Zidovudine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000219	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000217	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000217	CcSEcCtD
Zidovudine—ABCC5—Disease—ENO2—peripheral nervous system neoplasm	4.66e-05	0.000841	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.65e-05	0.00084	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.65e-05	0.000839	CbGpPWpGaD
Zidovudine—Pain—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000215	CcSEcCtD
Zidovudine—Constipation—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000215	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000212	CcSEcCtD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.56e-05	0.000823	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	4.55e-05	0.000821	CbGpPWpGaD
Zidovudine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000211	CcSEcCtD
Zidovudine—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.53e-05	0.000817	CbGpPWpGaD
Zidovudine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000209	CcSEcCtD
Zidovudine—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.48e-05	0.000809	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.47e-05	0.000807	CbGpPWpGaD
Zidovudine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000208	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000207	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000207	CcSEcCtD
Zidovudine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.42e-05	0.000206	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000205	CcSEcCtD
Zidovudine—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	4.38e-05	0.000791	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.37e-05	0.000788	CbGpPWpGaD
Zidovudine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000202	CcSEcCtD
Zidovudine—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	4.34e-05	0.000784	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	4.33e-05	0.000781	CbGpPWpGaD
Zidovudine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000201	CcSEcCtD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.32e-05	0.00078	CbGpPWpGaD
Zidovudine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000201	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.0002	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000199	CcSEcCtD
Zidovudine—Pain—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000199	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000199	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000199	CcSEcCtD
Zidovudine—TERT—Cell Cycle—TP53—peripheral nervous system neoplasm	4.28e-05	0.000772	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.16e-05	0.000751	CbGpPWpGaD
Zidovudine—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.14e-05	0.000748	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.14e-05	0.000746	CbGpPWpGaD
Zidovudine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000192	CcSEcCtD
Zidovudine—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	4.12e-05	0.000744	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.11e-05	0.000742	CbGpPWpGaD
Zidovudine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.00019	CcSEcCtD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	4.08e-05	0.000735	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.05e-05	0.000731	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.98e-05	0.000718	CbGpPWpGaD
Zidovudine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000185	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000184	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000184	CcSEcCtD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.91e-05	0.000705	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ENO2—peripheral nervous system neoplasm	3.9e-05	0.000704	CbGpPWpGaD
Zidovudine—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000181	CcSEcCtD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.83e-05	0.000692	CbGpPWpGaD
Zidovudine—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000178	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.78e-05	0.000682	CbGpPWpGaD
Zidovudine—TERT—Disease—ERBB2—peripheral nervous system neoplasm	3.77e-05	0.00068	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SLC2A1—peripheral nervous system neoplasm	3.76e-05	0.000678	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.74e-05	0.000676	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.73e-05	0.000673	CbGpPWpGaD
Zidovudine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.73e-05	0.000673	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.71e-05	0.00067	CbGpPWpGaD
Zidovudine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000172	CcSEcCtD
Zidovudine—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.67e-05	0.000663	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.62e-05	0.000654	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	3.62e-05	0.000653	CbGpPWpGaD
Zidovudine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000167	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000166	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000165	CcSEcCtD
Zidovudine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.49e-05	0.000629	CbGpPWpGaD
Zidovudine—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.00016	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000159	CcSEcCtD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.41e-05	0.000616	CbGpPWpGaD
Zidovudine—Rash—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000159	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000159	CcSEcCtD
Zidovudine—Headache—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000158	CcSEcCtD
Zidovudine—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.39e-05	0.000611	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.38e-05	0.00061	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.34e-05	0.000603	CbGpPWpGaD
Zidovudine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000154	CcSEcCtD
Zidovudine—ABCC5—Metabolism—BCHE—peripheral nervous system neoplasm	3.3e-05	0.000595	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	3.27e-05	0.000591	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.26e-05	0.000588	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	3.24e-05	0.000585	CbGpPWpGaD
Zidovudine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000149	CcSEcCtD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.2e-05	0.000577	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	3.19e-05	0.000576	CbGpPWpGaD
Zidovudine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000148	CcSEcCtD
Zidovudine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000147	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000147	CcSEcCtD
Zidovudine—ABCC5—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.14e-05	0.000568	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	3.14e-05	0.000566	CbGpPWpGaD
Zidovudine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000146	CcSEcCtD
Zidovudine—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	3.11e-05	0.00056	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—TH—peripheral nervous system neoplasm	3.1e-05	0.000559	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	3.02e-05	0.000545	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.01e-05	0.000542	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	2.99e-05	0.00054	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	2.97e-05	0.000537	CbGpPWpGaD
Zidovudine—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000138	CcSEcCtD
Zidovudine—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	2.88e-05	0.000519	CbGpPWpGaD
Zidovudine—TERT—Disease—NRAS—peripheral nervous system neoplasm	2.87e-05	0.000518	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	2.85e-05	0.000515	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.81e-05	0.000507	CbGpPWpGaD
Zidovudine—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.79e-05	0.000504	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.75e-05	0.000496	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	2.74e-05	0.000495	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.72e-05	0.00049	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.69e-05	0.000486	CbGpPWpGaD
Zidovudine—TERT—Disease—MYC—peripheral nervous system neoplasm	2.67e-05	0.000482	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.67e-05	0.000481	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.64e-05	0.000476	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GNAS—peripheral nervous system neoplasm	2.53e-05	0.000457	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.51e-05	0.000453	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ABCB1—peripheral nervous system neoplasm	2.48e-05	0.000448	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.45e-05	0.000442	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	2.43e-05	0.000439	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.42e-05	0.000436	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.4e-05	0.000432	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.36e-05	0.000426	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.34e-05	0.000421	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.32e-05	0.000419	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.32e-05	0.000418	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.29e-05	0.000413	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	2.29e-05	0.000412	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.27e-05	0.000409	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	2.24e-05	0.000404	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.23e-05	0.000403	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.11e-05	0.00038	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTPN11—peripheral nervous system neoplasm	2.1e-05	0.000379	CbGpPWpGaD
Zidovudine—TERT—Disease—HRAS—peripheral nervous system neoplasm	2.1e-05	0.000379	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.08e-05	0.000376	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.05e-05	0.000371	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.03e-05	0.000367	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GNS—peripheral nervous system neoplasm	2.02e-05	0.000365	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.02e-05	0.000364	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.01e-05	0.000362	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.98e-05	0.000358	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.96e-05	0.000354	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.96e-05	0.000353	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.95e-05	0.000351	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.94e-05	0.000349	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.9e-05	0.000343	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.87e-05	0.000338	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.87e-05	0.000338	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.87e-05	0.000337	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.86e-05	0.000337	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.86e-05	0.000336	CbGpPWpGaD
Zidovudine—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.86e-05	0.000336	CbGpPWpGaD
Zidovudine—TERT—Disease—AKT1—peripheral nervous system neoplasm	1.85e-05	0.000334	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.85e-05	0.000333	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.83e-05	0.00033	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.81e-05	0.000327	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.81e-05	0.000326	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.8e-05	0.000325	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.77e-05	0.000319	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.74e-05	0.000314	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AKT1—peripheral nervous system neoplasm	1.72e-05	0.00031	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.7e-05	0.000306	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.69e-05	0.000306	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.68e-05	0.000302	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.67e-05	0.000302	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.66e-05	0.0003	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB2—peripheral nervous system neoplasm	1.66e-05	0.000299	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-05	0.000299	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.65e-05	0.000298	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.63e-05	0.000295	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.6e-05	0.000288	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.59e-05	0.000286	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.000285	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.58e-05	0.000284	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	1.56e-05	0.000281	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.55e-05	0.000279	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.54e-05	0.000277	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.53e-05	0.000275	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.52e-05	0.000275	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.51e-05	0.000272	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.48e-05	0.000268	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.47e-05	0.000265	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.46e-05	0.000263	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.45e-05	0.000262	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.43e-05	0.000258	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.38e-05	0.00025	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.36e-05	0.000245	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.32e-05	0.000239	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.3e-05	0.000234	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000232	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.00023	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NRAS—peripheral nervous system neoplasm	1.26e-05	0.000228	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.26e-05	0.000228	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000225	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	0.000222	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-05	0.000221	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.2e-05	0.000216	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—peripheral nervous system neoplasm	1.18e-05	0.000212	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-05	0.000211	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000211	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.15e-05	0.000207	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	1.1e-05	0.000198	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.09e-05	0.000197	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.07e-05	0.000193	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.05e-05	0.000189	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000188	CbGpPWpGaD
Zidovudine—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-05	0.000187	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.03e-05	0.000185	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000182	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.01e-05	0.000182	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1e-05	0.000181	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.92e-06	0.000179	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.86e-06	0.000178	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	9.78e-06	0.000176	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TH—peripheral nervous system neoplasm	9.72e-06	0.000175	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	9.28e-06	0.000168	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—peripheral nervous system neoplasm	9.24e-06	0.000167	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	9.06e-06	0.000163	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.85e-06	0.00016	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	8.73e-06	0.000157	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.64e-06	0.000156	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	8.52e-06	0.000154	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	8.46e-06	0.000153	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	8.18e-06	0.000148	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—peripheral nervous system neoplasm	8.16e-06	0.000147	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.07e-06	0.000146	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	7.98e-06	0.000144	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	7.96e-06	0.000144	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	7.94e-06	0.000143	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	7.83e-06	0.000141	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	7.79e-06	0.000141	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	7.12e-06	0.000129	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	6.99e-06	0.000126	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.95e-06	0.000125	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—peripheral nervous system neoplasm	6.83e-06	0.000123	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	6.61e-06	0.000119	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	6.5e-06	0.000117	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	6.37e-06	0.000115	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	6.26e-06	0.000113	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	5.98e-06	0.000108	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.58e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.32e-06	9.61e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	5.28e-06	9.53e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	5.25e-06	9.47e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	5.04e-06	9.09e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.28e-06	7.73e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.2e-06	7.59e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.47e-06	6.26e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.44e-06	6.2e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-06	5.69e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.15e-06	3.89e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	2.14e-06	3.87e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.92e-06	3.47e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.88e-06	3.39e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-06	3.16e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-06	2.09e-05	CbGpPWpGaD
